FDA — authorised 23 January 2015
- Marketing authorisation holder: ROCKWELL MEDICAL INC
- Status: approved
🇺🇸 Triferic in United States
FDA authorised Triferic on 23 January 2015
Marketing authorisations
FDA — authorised 23 January 2015
- Application: NDA206317
- Marketing authorisation holder: ROCKWELL MEDICAL INC
- Local brand name: TRIFERIC
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Triferic in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Triferic approved in United States?
Yes. FDA authorised it on 23 January 2015; FDA authorised it on 23 January 2015.
Who is the marketing authorisation holder for Triferic in United States?
ROCKWELL MEDICAL INC holds the US marketing authorisation.